What was once invisible will become visible—and that changes everything
For decades, the machinery of life has hidden in plain sight — too small, too faint, too easily lost in noise for even the most powerful microscopes to resolve. Physicists at UC Berkeley have now bent light itself to the problem, installing a laser of almost mythic intensity into a cryo-electron microscope to conjure contrast from the invisible. The result is a window into the structural world of small proteins — the vast majority of the human proteome — that has, until now, remained dark to science.
- Cryo-EM's Nobel Prize-winning power has always carried a quiet failure: roughly 90% of human proteins are too small to image clearly, leaving most of the proteome structurally uncharted.
- A 75-kilowatt continuous laser — more intense than military systems, the brightest focused beam ever built — now shifts electron phases inside a Titan Krios microscope, generating contrast without degrading the signal.
- Early tests on hemoglobin showed immediate gains: sharper images, recovered data from frames once too noisy to use, and improved 3D classification — all within standard imaging workflows.
- The stakes extend beyond single proteins: cryo-electron tomography, which images molecules inside living cells, stands to gain the contrast leap researchers have long needed to find signal in biology's most crowded environments.
- Biohub is already engineering a dual-laser successor, and the team has set its sights on proteins as small as 17 kilodaltons — a threshold that would unlock structural access to disease targets previously beyond reach.
Physicists at UC Berkeley and Lawrence Berkeley National Laboratory have installed a laser phase plate into a cryo-electron microscope — a heavily customized Titan Krios — and in doing so have addressed one of structural biology's most persistent blind spots. The work, led by physicist Holger Mueller and published in Science, uses an extraordinarily intense laser beam to shift the phase of electrons passing through it, generating true phase contrast without dimming or destabilizing the beam itself.
The problem the device solves has always been easy to state and hard to fix. Cryo-EM transformed structural biology and earned a Nobel Prize in 2017, but it struggles badly with proteins smaller than roughly 70 kilodaltons — a threshold that excludes approximately 90 percent of human proteins. Signal collapses into noise, and the structural details that matter most for disease research and drug discovery simply disappear.
The laser Mueller's team built is, by any measure, extraordinary: 75 kilowatts of continuous power focused to a few microns across, more intense than welding equipment or military systems. When tested on hemoglobin — a protein near the edge of conventional cryo-EM's range — the improvement was immediate. Motion correction sharpened, early imaging frames that are normally discarded became usable, and three-dimensional classification improved, all without requiring new reconstruction workflows.
The implications reach beyond single-particle analysis. Bridget Carragher of Biohub describes cryo-electron tomography — which reconstructs proteins inside intact cells — as searching for one leaf on one tree in a forest. In that dense biological environment, contrast is everything, and the laser phase plate promises to deliver it. Biohub is already developing a dual-laser version to reduce component wear and optical aberrations, while Mueller's team pushes toward imaging proteins as small as 17 kilodaltons. What was structurally invisible, as Biohub's Stephani Otte puts it plainly, is becoming visible — and that changes the terms of how science understands disease.
Imagine looking through a microscope and suddenly the blur resolves into perfect clarity. That's what happened to structural biology this week, courtesy of a laser so powerful it rivals military weapons, now trained on one of science's most stubborn problems: seeing the proteins that make up most of life.
Physicists at UC Berkeley and Lawrence Berkeley National Laboratory have installed a laser phase plate into a cryo-electron microscope—a Titan Krios, customized for the job—and in doing so, they've cracked open a door that's been stuck for years. The device, described in a paper published in Science and led by physicist Holger Mueller, uses an extraordinarily intense laser beam to shift the phase of electrons themselves, creating contrast without degrading the signal. The result is sharp, usable images of proteins so small that conventional cryo-EM has always struggled to see them clearly.
The problem the laser solves is deceptively simple to state and brutally hard to fix. Cryo-electron microscopy revolutionized structural biology a decade ago—it won a Nobel Prize in 2017—because it let scientists determine protein shapes without having to crystallize them first. But the technique has a blind spot: proteins smaller than about 70 kilodaltons are nearly invisible to it. The signal-to-noise ratio collapses. And here's the kicker—roughly 90 percent of human proteins fall below that threshold. The vast majority of the proteome has remained structurally dark.
The laser phase plate changes the math. Mueller describes the laser itself in almost mythic terms: 75 kilowatts of continuous power focused to a few microns across. More intense than welding equipment. More powerful than a military laser. The brightest continuous laser focus ever built. That focused beam shifts the phase of the electron beam passing through it, creating true phase contrast—the kind of contrast that lets you see fine detail—without dimming or destabilizing the electrons themselves. It's elegant physics applied to a concrete problem.
When the team installed the system and tested it, the improvement was immediate and measurable. They imaged hemoglobin, a protein that sits right at the edge of what today's cryo-EM can handle, and the laser phase plate made it visible with new clarity. The system enhanced motion correction—the ability to track and compensate for specimen movement during imaging. It recovered information from the earliest frames of data collection, frames that are usually too noisy to use. It improved particle visualization, three-dimensional classification, and alignment. All of this using standard imaging protocols and reconstruction workflows. No exotic new procedures required.
The breakthrough matters most for the hardest cases: small proteins, degraded samples, the biological material that's difficult to work with. But the real promise extends beyond single-particle analysis into cryo-electron tomography, a technique that assembles multiple angled views of a molecule into a three-dimensional reconstruction. Cryo-ET is used to image proteins and complexes inside cells, in their native crowded environment. Bridget Carragher, founding technical director of imaging at Biohub, describes it as searching for one leaf on one tree in a forest—the cell is so densely packed with machinery that contrast becomes everything. The laser phase plate promises to give cryo-ET the contrast leap it's been waiting for.
Biohub is already developing a dual-laser version of the system, designed to reduce wear on components and minimize optical aberrations. Mueller's team is pushing toward imaging proteins as small as 17 kilodaltons—a threshold that would open access to vast swaths of the human proteome that have never been structurally characterized. Stephani Otte, Biohub's vice president of imaging science, frames it plainly: what was invisible will become visible, and that changes everything about how we understand disease. Mueller himself offers a more measured assessment—the laser phase plate is essential for small proteins and poor samples, less critical for large proteins in pristine condition. But for the proteins that matter most in drug discovery and disease research, the ones that are small and hard to work with, this is the tool that fills the gap.
Citações Notáveis
This technology is a step function change for biology. What was once invisible will become visible—and that changes everything about how we understand disease.— Stephani Otte, Biohub vice president of imaging science
For the most challenging cases—small particles, bad specimens—the laser produces a very considerable advantage.— Holger Mueller, UC Berkeley physicist
A Conversa do Hearth Outra perspectiva sobre a história
Why does size matter so much in cryo-EM? Why can't you just image a small protein the same way you image a large one?
It's a signal-to-noise problem. When you're imaging a small protein, there's less material scattering electrons, so the signal is weaker. The noise stays constant. The ratio gets worse. Below 70 kilodaltons, the noise drowns out the detail you're trying to see.
And the laser phase plate fixes that by doing what, exactly?
It shifts the phase of the electron beam itself. That creates contrast—the ability to distinguish the protein from the background—without dimming the beam or making it unstable. It's like turning up the volume on a quiet signal without introducing static.
The laser sounds absurdly powerful. Why does it need to be that intense?
You're focusing 75 kilowatts to a few microns. That's an enormous amount of energy in a tiny space. But that intensity is what lets you create the phase shift you need without the beam losing coherence or stability. It's counterintuitive—you need that much power to do something so delicate.
What happens next? Is this technology ready to use, or is it still experimental?
It's installed and working in a custom microscope right now. But Biohub is already building improved versions. The real frontier is pushing down to 17-kilodalton proteins. That would unlock access to proteins that have never been structurally characterized before.
And that matters because?
Because most of the human proteome is small. If you can see those proteins, you can understand how they work, how they fail in disease, how to target them with drugs. Right now, they're invisible. This makes them visible.